TY  - JOUR
TI  - Adult Cardiovascular Surgery During COVID-19 Pandemic: A Retrospective Single Center Experience
AB  - Objective: Coronavirus disease-2019 (COVID-19), caused by a novel coronavirus, has become a worldwide pandemic. In order to control the global spread of this contagious disease, elective surgeries including cardiac and vascular procedures were postponed. In this article we present our experience during the initial phase of the pandemic in view of safety protocols. Material and Methods: The study included all elective, urgent, and emergent procedures that were performed from March 11, 2020 to June 30, 2021 at the depart- ment of cardiovascular surgery. Patients’ demographics, preoperative COVID-19 (reverse transcription-polymerase chain reaction) test re- sults, surgical procedures, complications and outcomes were prospec- tively collected. We also developed our own protocol to proceed with our surgical activity without delay.Results: A total of 86 cardiac and vascular procedures were performed during the study period. The me- dian age was 64 years (range 23-79), 59 (69%) were males. There were 42 (48%) elective procedures, and 13 (15%) patients had emer- gency procedures. 57 (66%) patients underwent coronary artery by- pass graft surgery. 10 (12%) patients underwent valvular procedures. Peripheral vascular surgeries were performed in 18 (21%) patients. The median length of stay in the hospital was 9 days (range 1-60). A positive COVID-19 test was identified in 4 patients, two of them were detected in the immediate postoperative period and died. In-hospital mortality was 9%. Conclusion: Cardiovascular procedures could be performed safely with a relatively low risk during the outbreak, par- ticularly for elective patients with proper management and strict in- fection control and isolation protocols.
AU  - ER, Zafer Cengiz
AU  - Çiçekçioğlu, Ferit
AU  - Ekim, Hasan
AU  - ALAGHA, SAMEH
AU  - Başar, Veysel
AU  - ekim, meral
DO  - 10.5336/cardiosci.2022-93651
PY  - 2022
JO  - Türkiye Klinikleri Cardiovascular Sciences
VL  - 34
IS  - 3
SN  - 1306-7656
SP  - 87
EP  - 96
DB  - TRDizin
UR  - http://search/yayin/detay/1173525
ER  -